Evaluation of FABP1 as a biomarker of diabetic kidney disease in children with type 1 diabetes
Hadil Mohamed Aboelenin, Heba ElTaher, Rasha Elzehery, Sara Mahmoud Nosir, Mohammad Al-Haggar · 2026
Read Evaluation of FABP1 as a biomarker of diabetic kidney disease in children with type 1 diabetes by Hadil Mohamed Aboelenin, Heba ElTaher, Rasha Elzehery, Sara Mahmoud Nosir, Mohammad Al-Haggar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13269410.txt.
Description
Hadil Mohamed Aboelenin and co-authors published a journal article in 2026 on an early marker of kidney damage in children with type 1 diabetes. The standard urine test often shows damage only after it is well established. A protein called FABP1, released when kidney tube cells are hurt, may signal damage sooner.
Ninety children were compared: 30 with kidney disease, 30 with diabetes but no kidney disease, and 30 healthy controls. Blood FABP1 was higher in the kidney disease group than in both other groups. It rose alongside the standard urine measure and blood fats. A cut point above 189 separated the groups, catching 63 percent of cases with 73 percent exactness. The authors propose it as an added test.
Catalog record
| CREATOR | Hadil Mohamed Aboelenin, Heba ElTaher, Rasha Elzehery, Sara Mahmoud Nosir, Mohammad Al-Haggar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27635 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |